Is There a Role for the Therapeutic Drug Monitoring of Colistin? An Overview.
Therapeutic Drug Monitoring (TDM)
colistin
multiresistant bacteria
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
06 Mar 2020
06 Mar 2020
Historique:
received:
31
01
2020
revised:
27
02
2020
accepted:
01
03
2020
entrez:
12
3
2020
pubmed:
12
3
2020
medline:
12
3
2020
Statut:
epublish
Résumé
Colistin is used as a last-line antibiotic for the treatment of Gram-negative multiresistant bacteria. Due to its high nephrotoxicity, Therapeutic Drug Monitoring (TDM) is recommended for dose adjustment. We aimed to evaluate the available evidence of TDM in patients given colistin to treat Gram-negative infections. In this paper, we offer an overview, using an electronic search of the literature (published up to June 2019, without language restrictions) that compares the clinical outcomes and measurements of colistin TDM. Ultimately, the Therapeutic Drug Monitoring (TDM) of colistin in Plasma could prevent nephrotoxicity risk.
Identifiants
pubmed: 32155714
pii: ph13030042
doi: 10.3390/ph13030042
pmc: PMC7151705
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Universidad de La Sabana
ID : MED-222-2017
Références
Ther Drug Monit. 2005 Feb;27(1):10-7
pubmed: 15665740
Int J Antimicrob Agents. 2016 Dec;48(6):725-727
pubmed: 28128096
Clin Infect Dis. 2018 Nov 13;67(suppl_2):S196-S205
pubmed: 30423057
J Med Chem. 2010 Mar 11;53(5):1898-916
pubmed: 19874036
SAGE Open Med Case Rep. 2017 Jun 19;5:2050313X17711630
pubmed: 28680633
J Med Microbiol. 2006 Dec;55(Pt 12):1619-1629
pubmed: 17108263
J Clin Monit Comput. 1999 Dec;15(7-8):529-44
pubmed: 12578052
Biol Pharm Bull. 2015;38(9):1430-3
pubmed: 26155936
Pharmacotherapy. 2019 Jan;39(1):10-39
pubmed: 30710469
J Antimicrob Chemother. 2011 Sep;66(9):2070-4
pubmed: 21715434
Ann Intensive Care. 2011 May 25;1(1):14
pubmed: 21906345
BMC Infect Dis. 2017 Jan 5;17(1):11
pubmed: 28056821
J Med Chem. 2016 Feb 11;59(3):1068-77
pubmed: 26734854
Int J Antimicrob Agents. 2018 Jul;52(1):90-95
pubmed: 29530587
Ther Drug Monit. 2019 Feb;41(1):102-106
pubmed: 30299430
BMC Infect Dis. 2013 Aug 19;13:380
pubmed: 23957376
J Clin Microbiol. 2019 Mar 28;57(4):
pubmed: 30541939
Can J Infect Dis Med Microbiol. 2017;2017:1839190
pubmed: 29181039
Clin Infect Dis. 2015 Dec 15;61(12):1778-80
pubmed: 26354966
Ann Pharmacother. 2008 Sep;42(9):1177-87
pubmed: 18664609
Int J Antimicrob Agents. 2016 Dec;48(6):614-621
pubmed: 27865627
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Feb 1;980:48-54
pubmed: 25589254
J Crit Care. 2013 Apr;28(2):219.e13-9
pubmed: 22762926
Antibiotics (Basel). 2019 Jul 24;8(3):
pubmed: 31344885
Health Info Libr J. 2009 Jun;26(2):91-108
pubmed: 19490148
Clin Infect Dis. 2013 Sep;57(6):877-83
pubmed: 23728146
Clin Infect Dis. 2014 Jul 1;59(1):88-94
pubmed: 24700659
J Bacteriol. 1947 Jul;54(1):24
pubmed: 20344246
Int J Antimicrob Agents. 2013 Oct;42(4):357-60
pubmed: 24011987
Int J Antimicrob Agents. 2014 Jan;43(1):1-6
pubmed: 23920094
Lancet Infect Dis. 2015 Feb;15(2):225-34
pubmed: 25459221
Clin Infect Dis. 2015 Jan 1;60(1):79-87
pubmed: 25246597
Crit Care Nurs Q. 2011 Apr-Jun;34(2):87-100
pubmed: 21407003
Front Microbiol. 2018 Oct 25;9:2568
pubmed: 30410479
Microb Drug Resist. 2017 Jun;23(4):468-472
pubmed: 27802107